Necdin and E2F4 are modulated by rosiglitazone therapy in diabetic human adipose and muscle tissue (Q42804710)

From Wikidata
Jump to navigation Jump to search
scientific article published on March 2006
edit
Language Label Description Also known as
English
Necdin and E2F4 are modulated by rosiglitazone therapy in diabetic human adipose and muscle tissue
scientific article published on March 2006

    Statements

    Necdin and E2F4 are modulated by rosiglitazone therapy in diabetic human adipose and muscle tissue (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit